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Summary
Background Rift Valley fever virus is an emerging mosquito-borne virus that causes infections in animals and human 
beings in Africa and the Arabian Peninsula. Outbreaks of Rift Valley fever lead to mass abortions in livestock, but 
such abortions have not been identiﬁ ed in human beings. Our aim was to investigate the cause of miscarriages in 
febrile pregnant women in an area endemic for Rift Valley fever.
Methods Pregnant women with fever of unknown origin who attended the governmental hospital of Port Sudan, 
Sudan, between June 30, 2011, and Nov 17, 2012, were sampled at admission and included in this cross-sectional 
study. Medical records were retrieved and haematological tests were done on patient samples. Presence of viral RNA 
as well as antibodies against a variety of viruses were analysed. Any association of viral infections, symptoms, and 
laboratory parameters to pregnancy outcome was investigated using Pearson’s χ² test. 
Findings Of 130 pregnant women with febrile disease, 28 were infected with Rift Valley fever virus and 31 with 
chikungunya virus, with typical clinical and laboratory ﬁ ndings for the infection in question. 15 (54%) of 28 women 
with an acute Rift Valley fever virus infection had miscarriages compared with 12 (12%) of 102 women negative for 
Rift Valley fever virus (p<0·0001). In a multiple logistic regression analysis, adjusting for age, haemorrhagic disease, 
and chikungunya virus infection, an acute Rift Valley fever virus infection was an independent predictor of having a 
miscarriage (odds ratio 7·4, 95% CI 2·7–20·1; p<0·0001).
Interpretation This study is the ﬁ rst to show an association between infection with Rift Valley fever virus and 
miscarriage in pregnant women. Further studies are warranted to investigate the possible mechanisms. Our ﬁ ndings 
have implications for implementation of preventive measures, and evidence-based information to the public in 
endemic countries should be strongly recommended during Rift Valley fever outbreaks.
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Introduction
Rift Valley fever is an emerging mosquito-borne 
infection caused by Rift Valley fever virus (genus 
Phlebovirus, family Bunyaviridae), with outbreaks in 
Africa and more recently also in the Arabian Peninsula. 
However, the virus has the potential to spread to other 
continents. The infection is characterised by a high 
case-fatality rate in young animals and causes mass 
abortions in cattle, goats, and sheep. In human beings, 
Rift Valley fever presents in most cases as a mild illness 
with inﬂ uenza-like symptoms. However, in 1–3% of 
cases it progresses to a more severe haemorrhagic 
disease involving liver necrosis, ocular disease, internal 
and external haemorrhaging, and encephalitis, which 
could be lethal.1
Infections during pregnancy pose a considerable threat 
to the mother and fetus. Emerging vector-borne 
infections by agents such as Zika virus, West Nile virus, 
Japanese encephalitis virus, Venezuelan equine 
encephalitis virus, malaria, brucellosis, and dengue can 
induce fetal malformation, miscarriage, or premature 
birth in human beings.2–7
Rift Valley fever virus has not previously been linked to 
miscarriage in pregnant women, although only a few 
studies have investigated this association. In one study 
from Mozambique, pregnant women seropositive for 
Rift Valley fever virus (IgG) showed a slightly higher 
frequency of stillbirth than seronegative women, but the 
diﬀ erence was not statistically signiﬁ cant.8 Case reports 
have described vertical transmission of Rift Valley fever 
virus in one pregnant woman in Sudan9 and in one case 
in Saudi Arabia, where transplacental transmission led 
to the death of the infant.10 Sudan has had several Rift 
Valley fever outbreaks,11,12 but the possible association 
with miscarriage in pregnant women is not known.
Our objective was to determine which infectious agents 
were the cause of miscarriage in a cross-sectional study 
of febrile pregnant women who attended a hospital in 
Port Sudan, Sudan.
Materials and methods
Study design and participants
In June, 2011, we noted an increase in patients with fever, 
many with haemorrhagic symptoms, arriving at the 
Lancet Glob Health 2016; 
4: e864–71
Published Online
September 27, 2016
http://dx.doi.org/10.1016/
S2214-109X(16)30176-0
See Comment page e773
*Contributed equally
Department of Clinical 
Microbiology, Virology, Umeå 
University, Umeå, Sweden 
(M Baudin MSc, 
Prof M Evander PhD, 
N Mohamed PhD); Department 
of Obstetrics and Gynaecology, 
Red Sea University, Port Sudan, 
Sudan (A M Jumaa MD); 
Department of Parasitology 
and Medical Entomology, 
Port Sudan Ahlia College, Port 
Sudan, Sudan 
(H J E Jomma MSc); Faculty of 
Medical Laboratory Sciences, 
Karary University, Khartoum, 
Sudan (M S Karsany PhD); 
Swedish Defence Research 
Agency, CBRN Defence and 
Security, Umeå, Sweden 
(G Bucht PhD, J Näslund PhD); 
and Department of Clinical 
Microbiology, Infectious 
Diseases, Umeå University, 
Umeå, Sweden 
(Prof Clas Ahlm PhD)
Correspondence to:
Prof Magnus Evander, 
Department of Clinical 
Microbiology, Virology, Umeå 
University, Umeå, Sweden
magnus.evander@umu.se
Articles
e865 www.thelancet.com/lancetgh   Vol 4   November 2016
governmental hospital of Port Sudan, Sudan. 
Simultaneously, the Department of Obstetrics and 
Gynaecology at the same hospital observed an increase in 
miscarriages among febrile women. Patients with these 
characteristics were examined and sampled between 
June 30, 2011, and Nov 17, 2012. Samples from patients 
whose fever could not be explained by bacterial infections, 
malaria, or yellow fever, and thus suspected to be of 
another viral origin, were stored for later analysis. We 
then retrieved clinical information and laboratory test 
results from the patients’ medical records and stored 
blood samples were analysed.
Ethical clearance was granted from the Regional Ethics 
Review Board at the Red Sea University in Sudan. All 
participants gave their consent after being informed 
about the objectives of the study and the conﬁ dentiality 
of the information and results.
Procedures
Venous blood samples were collected 2–5 days after the 
onset of illness. Shortly after the initial sampling, 
haemoglobin, haematocrit, total white blood cell count, 
and platelet count were measured with a haematology 
analyser (Kx 21; Sysmex, Kobe, Japan). Plasma samples 
were prepared from the blood and stored at −20°C. Later, 
total RNA was extracted using the QIAamp viral RNA 
mini kit (Qiagen, Hilden, Germany), and recovered in 
20 μL of nuclease-free water. The RNA obtained was 
either stored at −80°C or used directly for cDNA synthesis 
using the GoScript Reverse Transcription System 
(Promega, Madison, WI, USA). Sera from the venous 
blood samples were spotted on ﬁ lter papers (FTA Cards; 
Whatman, GE Healthcare, Maidstone, UK), dried, and 
stored as described previously.13 Elution of samples from 
ﬁ lter papers was done at room temperature under 
constant rocking of ﬁ lter cut-outs (1 cm² in area) in 1 mL 
of phosphate-buﬀ ered saline for 30 min. After this 
elution, which corresponded to a 1 in 25 dilution, the 
samples were stored at 4°C for analysis.
Eluted patient samples were prepared and analysed by 
qRT-PCR for Rift Valley fever virus RNA, chikungunya 
virus RNA, hepatitis E virus RNA, and dengue virus RNA 
using the primers and probes listed in table 1. For the 
probe-based PCR assays (Rift Valley fever virus, 
chikungunya virus, and hepatitis E virus), a qRT-PCR 
QuantiTect Probe PCR kit was used (Qiagen, Hilden, 
Germany). The assay was done in a 25-μL ﬁ nal reaction 
volume containing 2 μL of cDNA, each primer at 400 nM, 
each probe at 225 nmol/L, and RNase-free water 
(Ambion; Thermo Fisher Scientiﬁ c, Waltham, MA, 
USA). The reaction was run for 2 min at 50°C and 15 min 
at 95°C, followed by 45 cycles of 94°C for 15 s and 60°C 
for 1 min. All samples were tested in duplicate (including 
positive and negative controls) in a 96-well reaction plate 
Research in context
Evidence before this study
We searched the PubMed database for studies published before 
May 8, 2016, using the MeSH terms “Rift Valley Fever”AND 
“Abortion, Spontaneous”AND “humans”. We found two 
relevant studies. By combining the MeSH terms “Rift Valley 
Fever”AND “Pregnancy”AND “humans” we found two relevant 
studies. We used no language restrictions. No additional 
articles or reports on the eﬀ ect of Rift Valley fever in pregnant 
women were found using other databases or resources (WHO, 
Google scholar, Web of Science). Very few studies have 
attempted to investigate Rift Valley fever and pregnancy loss 
in human beings. Two retrospective studies, based on 
seroepidemiology, have investigated the relationship between 
Rift Valley fever and miscarriage or stillbirth in human beings. 
Although they did not detect an association between Rift 
Valley fever virus infection and miscarriage or stillbirth in 
human beings, the absence of reporting mechanisms in these 
countries (Egypt in 1978, Mozambique in 1983) would 
underestimate the actual miscarriage or stillbirth rate. 
However, two case reports found evidence of vertical 
transmission of Rift Valley fever virus in human beings. In 
animals, especially livestock, Rift Valley fever virus infection is 
almost 100% abortogenic at all stages of pregnancy. Rift Valley 
fever virus has been found in both placental and fetal tissue in 
aborted goats, deer, and sheep.
Added value of this study
The authors of the articles described above stated that there is a 
need for further studies into a possible link between Rift Valley 
fever virus and miscarriage in pregnant women, preferably 
during an outbreak in order to observe the eﬀ ect of an acute 
infection. Our study has investigated for the ﬁ rst time an 
association between acute Rift Valley fever virus infection and 
miscarriage in a relatively large number of pregnant women 
with fever attending the hospital in Port Sudan. We found a 
signiﬁ cant association between acute Rift Valley fever virus 
infection and miscarriage. Rift Valley fever is in several ways a 
neglected disease, and the role of Rift Valley fever virus infection 
in miscarriage or stillbirth in human beings has not been 
recognised. This could be due to the fact that Rift Valley fever 
outbreaks mostly occur in rural areas in low-income countries 
that generally lack proper abortion records, have limited access 
to health care and diagnosis, especially during outbreaks.
Implications of the available evidence
Our ﬁ ndings have implications for implementation of 
preventive measures, and evidence-based information for the 
public in endemic countries is crucial during Rift Valley fever 
outbreaks. Preventive measures should be introduced to avoid 
Rift Valley fever virus infection; for example, women at a fertile 
age could be given information on the eﬀ ect of Rift Valley fever 
during pregnancy and how to avoid being infected. 
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using the ABI Prism 7900HT Sequence Detection 
System 2.4 (Applied Biosystems; Thermo Fisher 
Scientiﬁ c). For detection of dengue virus, an SYBR 
green-based assay was done as previously described.14 For 
sequencing, PCR products of Rift Valley fever virus 
positive cDNA samples were generated by using Rift 
Valley fever virus forward and reverse primers (table 1). 
The ampliﬁ ed fragments were sequenced (Euroﬁ ns 
Genomics, Ebersberg, Germany) to conﬁ rm the Rift 
Valley fever virus qRT-PCR results.
Dengue IgM was detected by enzyme-linked 
immunosorbent assay using a PanBio Dengue Early 
ELISA kit (PanBio, Brisbane, Australia). Acute hepatitis 
B virus infection (HBsAg and anti-HBc), and acute 
hepatitis A virus infection (IgM) were analysed with an 
Abbot Architect i4000SR (Abbott Laboratories, Chicago. 
IL, USA). Antibodies to Rift Valley fever virus were 
detected by IgM analysis using an attenuated Rift Valley 
fever virus15 in an assay we have previously described.16 
The presence of neutralising antibodies to Rift Valley 
fever virus in serum samples was detected using a plaque 
reduction neutralisation test as previously described.17 In 
brief, eluted patient samples (at a ﬁ nal dilution of 1:100) 
were pre-incubated for 60 min with 50 plaque-forming 
units of Rift Valley fever virus strain MP12 in Dulbecco’s 
minimal essential medium (Gibco; Thermo Fisher 
Scientiﬁ c) in a ﬁ nal volume of 200 μL. The samples were 
added to nearly conﬂ uent baby hamster kidney (BHK)-21 
cells in 12-well plates for virus attachment, and incubated 
for 1 h. After removing the samples and washing once 
with phosphate-buﬀ ered saline, 2 mL of a 1·5% aquacide 
(Calbiochem; Merck Millipore, Darmstadt, Germany) 
overlay in Dulbecco’s minimal essential medium 
supplemented with 2·5% fetal bovine serum and 0·5% 
penicillin and streptomycin (10 000 U/mL) was added to 
the wells. The plates were incubated at 37°C in an 
atmosphere of 5% CO2 for 6 days. The cells were ﬁ xed in 
10% paraformaldehyde in phosphate-buﬀ ered saline for 
2 h before rinsing in tap water and counterstained using 
crystal violet. After destaining with water, samples with 
more than 70% plaque reduction were considered 
positive.
Deﬁ nitions
Pregnancy outcome was deﬁ ned as normal pregnancy 
(delivery of a healthy baby at full term), preterm delivery 
(delivery of a healthy baby at 8 months of gestation or 
earlier), and miscarriage (pregnancy loss at any stage of 
pregnancy). Early miscarriage was deﬁ ned as occurring 
at 3 months’ gestation or earlier (ﬁ rst trimester), whereas 
a pregnancy loss at or after 4 months’ gestation was 
classiﬁ ed as a late miscarriage (second and third 
trimester). To be positive for acute Rift Valley fever virus 
infection, patients had to be positive for Rift Valley fever 
virus RNA in qRT-PCR or positive for Rift Valley fever 
virus IgM antibodies using ELISA conﬁ rmed by a plaque 
reduction neutralisation test. Patients who were IgM 
positive but negative by PCR and plaque reduction 
neutralisation test were classiﬁ ed as Rift Valley fever 
virus negative. For classiﬁ cation of severe disease, we 
constructed a category named haemorrhagic disease in 
which we included patients with any bleeding 
symptoms or moderate-to-severe thrombocytopenia 
(<100 × 10⁹ platelets per L).
Statistical analysis
SPSS Statistics 23.0 (IBM, Armonk, NY, USA) was used 
for statistical analysis. Miscarriage was the chief outcome 
variable. Categorical data such as pregnancy outcome, 
clinical symptoms in Rift Valley fever virus or 
chikungunya virus positive compared with negative 
patients, and if haemorrhagic disease was correlated with 
miscarriage, were analysed using Pearson’s χ² test. 
Fisher’s exact test was used in analysing the timing of 
miscarriages (early vs late) between patients positive and 
negative for Rift Valley fever virus. Analysis of the 
relation of scale variables (age, total white blood cell 
counts, platelets, haemoglobin, and haematocrit) to Rift 
Valley fever virus or chikungunya virus infection was 
done with independent-samples t tests. Multiple logistic 
regression was used to calculate the odds ratio (OR) for 
risk of miscarriage depending on Rift Valley fever virus 
infection with adjustment for age, haemorrhagic disease, 
and chikungunya virus infection. To test if chikungunya 
virus infection aﬀ ected the association between Rift 
Valley fever virus infection and risk of miscarriage, the 
chikungunya virus by Rift Valley fever virus interaction 
was added to the model. CIs were set at 95% and 
statistical signiﬁ cance was 0·05.
Role of the funding source
The funder of the study had no role in the study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Sequence
RVFV PCR forward primer 5’-AAGGCAAAGCAACTGTGGAG-3’
RVFV PCR reverse primer 5’-CAGTGACAGGAAGCCACTCA-3’
RVFV PCR probe 5’- GATGAGTTGACTCTATCACGAGTTGC-3’
CHIKV PCR forward primer 5’-CATGCAAAACAGAATTTGC-3’
CHIKV PCR reverse primer 5’-TAGGCAGTTACAGTGATG-3’
CHIKV PCR probe 5’-CTCATACCGCATCTGCATCA-3’
HEV PCR forward primer 5’-GGTGGTTTCTGGGGTGAC-3’
HEV PCR reverse primer 5’-AGGGGTTGGTTGGATGAA-3’
HEV PCR probe 5’-TGATTCTCAGCCCTTCGC-3’
DENV PCR forward primer 5’-TCAATATGCTGAAACGCGAGAGAAACCG-3’
DENV PCR forward primer 5’-TTGCACCAACAGTCAATGTCTTCAGGTTC-3’
RVFV=Rift Valley fever virus. CHIKV=chikungunya virus. HEV=hepatitis E virus. DENV=dengue virus.
Table 1: Primers and probes used in the qRT-PCR analyses 
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Results
Of 162 patients whose samples were stored for analysis, 
130 pregnant women were included in the study. 
32 patients were excluded from the analysis: one 
deceased pregnant woman, seven non-pregnant women 
(of which one succumbed to disease), and 24 men, 
although some analyses were done on their samples. Of 
the 130 surviving pregnant women, four had premature 
deliveries and 27 had miscarriages. Two women 
miscarried in the ﬁ rst trimester (early miscarriage), 17 in 
the second trimester, and four in the third trimester (late 
miscarriage); gestational age was unknown in four 
miscarriages. Four women had preterm deliveries; two at 
7 months of gestation and two at 8 months (table 2). The 
mean age of the participants was 27 years (range 17–40). 
According to the medical records, all women in the study 
had nausea or vomiting, jaundice, and joint pain in 
addition to other inﬂ uenza-like symptoms such as fever, 
headache, and generalised pain. Malaise, diarrhoea, and 
rash were experienced by 52 (40%), 46 (35%), and 
40 (31%) women, respectively, whereas 21 (16%) women 
had bleeding symptoms (subconjunctival bleeding, 
epistaxis, vaginal bleeding; table 2).
Before our analysis, the patient samples were negative 
for malaria, bacterial infections, and yellow fever. Viral 
RNA in blood is a sign of acute infection, and by 
analysing the samples for several virus infections by qRT-
PCR we found that many patients were positive for Rift 
Valley fever virus and chikungunya virus RNA, whereas 
none were positive for hepatitis E virus or dengue virus 
RNA. Of the 130 pregnant women, 28 (22%) tested 
positive for an acute Rift Valley fever virus infection by 
qRT-PCR or IgM detection, whereas 31 (24%) were PCR-
positive for chikungunya virus RNA (table 2). Eight 
patients were co-infected with both viruses. No patients 
had acute hepatitis A virus or hepatitis B virus infection, 
but nine patients had IgM antibodies to dengue virus 
(table 2). A selection of Rift Valley fever virus qRT-PCR 
ampliﬁ cation products were conﬁ rmed positive by 
sequencing (appendix).
The Rift Valley fever virus IgM-positive samples were 
further tested with a plaque reduction neutralisation test 
to conﬁ rm the presence of Rift Valley fever virus 
antibodies; 12 (71%) of 17 were positive in this assay (data 
not shown). Two of the samples negative by the plaque 
reduction neutralisation test were positive for Rift Valley 
fever virus RNA and classiﬁ ed as Rift Valley fever virus 
positive. The remaining three were regarded as Rift 
Valley fever virus negative.
The temporal distribution showed more pregnant 
women positive for Rift Valley fever virus and 
chikungunya virus from July to September in both 2011 
and 2012 (ﬁ gure). To assess if there were more cases of 
Rift Valley fever during the study period we also analysed 
samples from the excluded patients. We found that three 
(13%) of 24 men but none of the non-pregnant women 
tested positive for Rift Valley fever virus RNA by qRT-
PCR. Two of the men were also positive for IgM but 
negative by PCR for dengue virus. Neither of the deceased 
women were positive for any infection tested for (data 
not shown).
When we analysed the association between virus 
infection and clinical and laboratory parameters, an 
acute Rift Valley fever virus infection was found to be 
signiﬁ cantly associated with bleeding, lower platelet 
counts, low haemoglobin concentrations, rash, and 
malaise (table 3). Chikungunya virus infection was 
associated with malaise, rash, high white blood cell 
count, low haemoglobin, and low haematocrit 
concentrations (table 4). Positivity for dengue virus IgM 
was not associated with adverse pregnancy outcome 
(data not shown).
Febrile pregnant 
women (n=130)
Age (years; mean [range, SD]) 27·0 (17–40, 5·5)
Pregnancy outcome
Normal pregnancy 99 (76%)
Miscarriage 27 (21%)
Preterm delivery 4 (3%)
Viral infections
RVFV infection (PCR or IgM ELISA or PRNT positive) 28 (22%)
CHIKV infection (PCR positive) 31 (24%)
RVFV/CHIKV coinfection 8 (6%)
DENV infection (IgM ELISA positive) 9 (7%)
DENV infection (PCR positive) 0
HEV infection (PCR positive) 0
HBV infection (HBsAg, anti-HBc positive) 0
HAV infection (HAV anti-IgM positive) 0
Clinical symptoms
Fever 130 (100%)
Headache 130 (100%)
Generalised pain 130 (100%)
Nausea or vomiting 130 (100%)
Jaundice 130 (100%)
Joint pain 130 (100%)
Malaise 52 (40%)
Diarrhoea 46 (35%)
Rash 40 (31%)
Bleeding 21 (16%)
Laboratory ﬁ ndings
Total white blood cell count (×10⁹ /L)* 7·5 (3·9)
Platelet count (×10⁹/L)† 201 (102)
Haemoglobin concentration (%)‡ 9·8 (1·8)
Haematocrit (%)§ 31·7 (5·3)
Data are n (%) or mean (SD), unless otherwise stated. RVFV=Rift Valley fever virus. 
PRNT=plaque reduction neutralisation test. CHIKV=chikungunya virus. 
DENV=dengue virus. HEV=hepatitis E virus. HBsAg=hepatitis B surface antigen. 
HBV=hepatitis B virus. HAV=hepatitis A virus. Normal range for pregnant 
women:18  *5·6–16·9. †146–429. ‡9·5–15·0. §28·0–41·0.
Table 2: Pregnancy outcome, clinical symptoms, and laboratory ﬁ ndings 
in febrile pregnant women in Port Sudan, Sudan 
See Online for appendix
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Of all virus infections studied here, only Rift Valley 
fever virus was associated with miscarriage. 15 (54%) of 
28 patients positive for Rift Valley fever virus had 
miscarriage compared with only 12 (12%) of 102 patients 
negative for Rift Valley fever virus (p<0·0001; table 3). 
There was no association between age and pregnancy 
outcome or to Rift Valley fever virus infection. In a 
multiple logistic regression analysis, adjusting for age, 
haemorrhagic disease, and chikungunya virus infection, 
an acute Rift Valley fever virus infection was an 
independent predictor of having a miscarriage (OR 7·4, 
95% CI 2·7–20·1; p<0·0001). Patients positive for Rift 
Valley fever virus with miscarriage (15 women) had 
bleeding (p=0·005), joint pain (p<0·0001), and malaise 
(p<0·0001) to a higher degree than patients positive for 
Rift Valley fever virus with normal pregnancy (12 women). 
Otherwise, these two patient groups were not signiﬁ cantly 
diﬀ erent regarding age and other clinical and laboratory 
parameters (table 3).
Eight (26%) of 31 patients infected with chikungunya 
virus had miscarriage compared with 19 (19%) of 
99 patients negative for Chikungunya virus (p=0·296; 
table 4). Five of the eight patients who had a Rift Valley 
fever virus and chikungunya virus co-infection had a 
miscarriage, but this interaction was not signiﬁ cant 
(p=0·573).
Gestational age of the pregnancy was known in 23 of 
the 27 women with miscarriage, and 12 of these were 
positive for Rift Valley fever virus. All 12 women with 
acute Rift Valley fever virus infection had a late 
miscarriage (second or third trimester), whereas four 
(36%) of 11 women who were negative for Rift Valley 
fever virus had an early miscarriage (ﬁ rst trimester). An 
acute Rift Valley fever virus infection was signiﬁ cantly 
associated with late miscarriage (p=0·037).
Of the four women with preterm delivery, one was co-
infected with Rift Valley fever virus and chikungunya 
virus, whereas two others were positive for chikungunya 
virus only. Preterm delivery was associated with 
chikungunya virus infection (p=0·034; table 4), but not 
with Rift Valley fever virus (table 3) or co-infection (data 
not shown).
Discussion
In this study we found that infection of pregnant women 
with Rift Valley fever virus was signiﬁ cantly associated 
with miscarriage. The results were conclusive and they 
have not been described before. Acute infection was 
detected using complementary methods; the presence of 
Rift Valley fever virus RNA was detected by qRT-PCR and 
anti-Rift Valley fever virus IgM antibodies with 
neutralising capacity. Moreover, the pregnant women 
who were positive for Rift Valley fever virus had 
characteristic clinical symptoms, as reported from 
several previous outbreaks.19 The women positive for Rift 
Valley fever virus who had miscarriage had more severe 
clinical symptoms than positive women with normal 
pregnancy, but laboratory parameters did not diﬀ er. 
Many other factors could aﬀ ect the severity of a Rift 
Valley fever virus infection, but those were not studied 
here.
Figure: Temporal distribution of patient samples during the study period
Temporal distribution of samples positive for Rift Valley fever virus and chikungunya virus in relation to all samples 
collected during the study period (June 30, 2011, to Nov 17, 2012). 
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Total number of collected patient samples
Number of Rift Valley fever virus-positive patient samples
Number of chikungunya virus-positive patient samples
Rift Valley 
fever virus 
positive 
(n=28)
Rift Valley 
fever virus 
negative 
(n=102)
p value
Age (years; mean [range, SD]) 27·8 (17–37, 
5·0)
26·8 (17–40, 
5·7)
0·382
Pregnancy outcome
Normal pregnancy 12 (43%) 87 (85%) <0·0001
Miscarriage 15 (54%) 12 (12%) <0·0001
Preterm delivery 1 (3%) 3 (3%) 0·422
Clinical symptoms
Malaise 19 (68%) 33 (32%) 0·001
Diarrhoea 8 (29%) 38 (37%) 0·395
Rash 10 (36%) 30 (29%) 0·522
Bleeding 11 (39%) 10 (10%) <0·0001
Haemorrhagic disease* 17 (61%) 31 (30%) 0·003
Laboratory ﬁ ndings
Total white blood cell count 
(×10⁹/L)
7·0 (3·5) 7·6 (4·0) 0·469
Platelet count (×10⁹/L) 161 (89) 211 (126) 0·050
Haemoglobin 
concentration (%)
9·1 (1·8) 10·0 (1·7) 0·024
Haematocrit (%) 30·2 (5·1) 32·1 (5·3) 0·091
Data are mean (SD) or n (%), unless otherwise stated. *Deﬁ ned as having any 
bleeding symptoms or moderate-to-severe thrombocytopenia 
(<100 × 10⁹ platelets per L).
Table 3: Association between Rift Valley fever virus positivity and 
pregnancy outcome, clinical symptoms, and laboratory ﬁ ndings
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Unfortunately, no placental or aborted fetal tissue was 
obtained for further analysis, which was a limitation of 
the present study. Further studies should be done to 
investigate the pathology and the possible presence of 
virus in such samples. Other limitations were a lack of 
records regarding miscarriages, stillbirths, and acute or 
historical Rift Valley fever cases in Port Sudan in human 
beings and livestock. Also, we could not follow up 
patients and newborns to study potential complications 
of the infection in those who did not miscarry.
In livestock, death of almost all newborns and abortions 
at all stages of pregnancy are early signs of an emerging 
Rift Valley fever outbreak. Fetuses often show marks of 
hepatic discoloration, haemorrhage, and necrosis.20,21 
Virus has been recovered from both aborted fetal material 
and placental tissue19 and it appears that placental 
necrosis or infection of the fetal liver might be major 
causes of abortion.20,21 In human beings, vertical 
transmission of Rift Valley fever virus has only been 
shown in two cases. One infected woman became ill a 
few days before an uneventful delivery. The infant was 
IgM-positive for Rift Valley fever virus and developed 
severe haemorrhagic symptoms, which led to his death 
6 days after admission to hospital.10 In another case, a 
38-week-pregnant woman with Rift Valley fever virus-like 
symptoms delivered a child with enlarged liver and skin 
rash. 3 days after birth, the child developed jaundice and 
both he and the mother tested positive for Rift Valley 
fever virus IgM.9 In the present study, all women with an 
acute Rift Valley fever virus infection had miscarriages 
that occurred in the second or third trimester of 
pregnancy. This ﬁ nding might suggest that Rift Valley 
fever virus infection at any stage of pregnancy could be 
deleterious. Direct infection of the fetus through the 
placental barrier or severe febrile disease could explain 
miscarriages. However, the mechanism behind the 
observed association between Rift Valley fever virus 
infection and miscarriage is not known and warrants 
further study.
There are many other possible causes of miscarriage 
in developing countries,22 which makes it probable that 
the importance of Rift Valley fever virus infection in 
this respect has not been properly recognised. When 
these infections emerge in new regions, they might as 
for other mosquito-borne viral infections (eg, Zika virus) 
reveal their true range of clinical disease.23 Acquired 
immunity in the endemic regions might restrict 
infections in females by the time they reach childbearing 
age and in these circumstances, the potential for a virus 
to cause intrauterine infections might not be detected 
until it is introduced into an immunologically naive 
population.3 In a study of the Rift Valley fever outbreak 
in Egypt in 1977, no increased rate of miscarriages was 
reported. The authors commented that most abortions 
occur in the home and that medical assistance from the 
clinic is usually sought only if complications develop.24
In Sudan the frequency of stillbirths (miscarriage after 
28 weeks) is estimated to be 2·4% of all pregnancies, 
14 times higher than in developed regions (as deﬁ ned for 
the Millennium Development Goals).25 Sudan has had 
several Rift Valley fever outbreaks,11,26 most recently in 
201012 in both human beings and livestock. Although the 
incidence of disease between the outbreaks has not been 
well studied, the virus is endemic in this area. Many 
other infectious diseases are also present in this region, 
and a fatal outbreak of hepatitis E virus in pregnant 
women occurred in Port Sudan before the start of our 
study.27 We detected Rift Valley fever virus infection in 
pregnant women and in men from the region, but no 
Rift Valley fever outbreak was reported by authorities in 
the Port Sudan area during the study time. The latest 
described Rift Valley fever outbreak in Sudan was in 
2010 in El Gezira state, but little is known about the 
cases and consequences.12 There is a dearth of 
information about the epidemiology and disease 
potential of Rift Valley fever in domestic livestock of 
Sudan. In a recent study, 9·4% of camels in Khartoum 
State, Sudan, sampled during 2014–15 had had a Rift 
Valley fever virus infection as measured by IgG 
antibodies.28 Furthermore, the main export market for 
Sudanese livestock is Saudi Arabia, just across the Red 
Sea from Port Sudan,29 and imported goats and sheep in 
Makkah, Saudi Arabia, during November 2011, showed a 
high prevalence of anti-Rift Valley fever virus IgG 
Chikungunya 
virus positive 
(n=31)
Chikungunya 
virus negative 
(n=99)
p value
Age (years; mean [range, SD]) 26·9 (18–36, 
4·4)
27·0 (17–40, 
5·9)
0·934
Pregnancy outcome
Normal pregnancy 20 (64%) 79 (80%) 0·081
Miscarriage 8 (26%) 19 (19%) 0·296
Preterm delivery 3 (10%) 1 (1%) 0·034
Clinical symptoms
Malaise 24 (77%) 28 (28%) <0·0001
Diarrhoea 8 (26%) 38 (38%) 0·201
Rash 31 (100%) 9 (9%) <0·0001
Bleeding 6 (19%) 15 (15%) 0·579
Haemorrhagic disease* 9 (29%)† 38 (38%) 0·297
Laboratory ﬁ ndings
Total white blood cell 
count (×10⁹/L)
9·1 (5·1) 7·0 (3·3) 0·006
Platelet count (×10⁹/L) 224 (97) 193 (126) 0·219
Haemoglobin 
concentration (%)
9·0 (1·1) 10·0 (1·8) 0·007
Haematocrit (%) 30·0 (4·9) 32·3 (5·3) 0·038
Data are n (%) or mean (SD), unless otherwise stated. *Deﬁ ned as having any 
bleeding symptoms or moderate-to-severe thrombocytopenia 
(<100 × 10⁹ platelets per L). †Four of these women had a chikungunya virus and 
Rift Valley fever virus co-infection.
Table 4: Association between chikungunya virus positivity and 
pregnancy outcome, clinical symptoms, and laboratory ﬁ ndings 
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(18%).30 This ﬁ nding indicates that Rift Valley fever virus 
could have been circulating among livestock in the Port 
Sudan region during the study period.
Both Rift Valley fever virus and chikungunya virus are 
transmitted by mosquitoes, which increase in numbers 
during the warm periods that follow after heavy 
rainfall.31 The rainy period in the Red Sea State is not as 
pronounced as in other Sudanese areas.32 In general, 
the wettest period in Sudan is in July–September, 
whereas in Port Sudan a short rainy season also appears 
during December–January.33 We noted an increase in 
the number of patients infected with Rift Valley fever 
virus and chikungunya virus for both 2011 and 2012 
mainly during July–September when the weather is 
warm and conditions are conducive for mosquitoes. 
This pattern is similar to the temporal pattern of 
dengue virus transmission in Port Sudan, where several 
transmission peaks were preceded by peaks of mosquito 
densities.33,34
Dengue is present in the Red Sea State, and maternal 
and fetal deaths due to dengue haemorrhagic fever have 
been observed in Port Sudan.4 However, neither 
hepatitis E virus nor dengue virus was associated with 
clinical disease in the present study. Chikungunya virus 
infection has been suspected to occur in Sudan,35 but 
only a few cases of IgM positivity have been described.36,37 
We detected chikungunya virus RNA in 24% of the 
patients and could describe their clinical symptoms, 
which were consistent with what has previously been 
reported.38,39 Chikungunya virus infection was not 
associated with miscarriage, but the high incidence in 
pregnant women indicates that chikungunya virus 
infections are relatively common in this coastal region. 
Although chikungunya virus has been shown to cross 
the placenta leading to fetal infection and miscarriage, 
this is a very rare occurrence.40 Perinatal infections 
with chikungunya virus, which can cause severe 
neurocognitive outcomes in the newborn, are also very 
rare.41 Interestingly, dual infection with Rift Valley fever 
virus and chikungunya virus was found in eight women 
but was not associated with miscarriage. Dual infections 
with mosquito-borne pathogens have been reported (eg, 
dengue virus and chikungunya virus38 and malaria 
together with several diﬀ erent arboviruses42), but 
the importance of such combined infections for 
disease development is not clear.
In conclusion, this study of 130 febrile pregnant 
Sudanese women showed that infection with Rift Valley 
fever virus was signiﬁ cantly associated with miscarriage. 
For animals, this correlation is well known, but it has not 
previously been described in human beings. Further 
studies are needed to investigate the possible mechanisms. 
Meanwhile, preventive measures should be implemented 
to avoid Rift Valley fever virus infection during pregnancy.
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